Predictors of the response of HbA1c and body weight after SGLT2 inhibition

Diabetes Metab. 2018 Mar;44(2):172-174. doi: 10.1016/j.diabet.2017.10.003. Epub 2017 Nov 8.

¹ Department of Haematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University, Niigata, Japan.
² Department of Haematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University, Niigata, Japan; Medical Information and Product Advancement Department, Kowa Pharmaceutical Company Ltd., Tokyo, Japan.
³ Clinical Data Science Department, Kowa Company Ltd., Tokyo, Japan.
⁴ Department of Haematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University, Niigata, Japan; Clinical Data Science Department, Kowa Company Ltd., Tokyo, Japan.
⁵ Department of Clinical Biostatistics, Graduate School of Medicine Kyoto University, Kyoto, Japan.
⁶ Department of Internal Medicine, Kawasaki Medical School, Okayama, Japan.
⁷ Department of Haematology, Endocrinology and Metabolism, Faculty of Medicine, Niigata University, Niigata, Japan. Electronic address: [email protected].

No abstract available

Publication types

Benzhydryl Compounds
Glucosides
Glycated Hemoglobin A
Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors
6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol